Literature DB >> 25916578

Neuronal tumour necrosis factor-α and interleukin-1β expression in a porcine model of intracerebral haemorrhage: Modulation by U-74389G.

Alexios Bimpis1, Apostolos Papalois2, Konstantinos Voumvourakis3, Orsolya Oláh4, Lazlo Tiszlavicz5, Charis Liapi6.   

Abstract

Tumour necrosis factor α (TNF-α) and interleukin 1β (IL-1β) are important mediators of intracerebral haemorrhage (ICH) inflammatory response. Lazaroids, established antioxidants and neuroprotectants, have been studied in several brain pathologies. The present study was designed to investigate: a) TNF-α and IL-1β changes, in neurons and b) U-74389G effects, 4 and 24h after haematoma induction in a porcine model of intracerebral haemorrhage. In twenty male landrace pigs (swines) aged 135-150 days old, autologous whole blood was injected around the right basal ganglia territory; in ten of the pigs the lazaroid compound U-74389G was administered. Brain TNF-α and IL-1β immunopositive neurons were determined by immunoarray techniques at 4 and 24h timepoints. After the haematoma induction the number of TNF-α immunopositive neurons ipsilateral to the haematoma was significantly higher compared to the contralateral site at 4h (p<0.0005), while U-74389G significantly reduced the number of TNF-α immunopositive neurons, ipsilateral to the haematoma, at 4h (p=0.002); at 24h, TNF-α immunopositive neurons were found significantly lower in the control group ipsilateral to the haematoma in comparison to 4h timepoint(p<0.0005). The number of IL-1β immunopositive neurons at 4h after the hematoma induction was significantly higher ipsilateral to the haematoma site (p<0.0005). U-74389G had no statistical significant effect. TNF-α and IL-1β, increase in neurons, 4h after the haematoma induction, ipsilateral to the haematoma site. The administration of the antioxidant compound U-74389G, results in early (at 4h) decrease of TNF-α immunopositive neurons but shows no statistical significant effect to IL-1β immunopossitive neurons.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  IL-1β; Intracerebral haemorrhage; Porcine model; TNF-α; U-74389G

Mesh:

Substances:

Year:  2015        PMID: 25916578     DOI: 10.1016/j.brainres.2015.04.034

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  PG2 for patients with acute spontaneous intracerebral hemorrhage: a double-blind, randomized, placebo-controlled study.

Authors:  Chun-Chung Chen; XianXiu Chen; Tsai-Chung Li; Hung-Lin Lin; Yen-Tze Chu; Han-Chung Lee; Yu-Kai Cheng; Der-Cherng Chen; Shiu-Chiu Tsai; Der-Yang Cho; Ching-Liang Hsieh
Journal:  Sci Rep       Date:  2017-03-31       Impact factor: 4.379

Review 2.  Pathophysiological Mechanisms and Potential Therapeutic Targets in Intracerebral Hemorrhage.

Authors:  Zhiwei Shao; Sheng Tu; Anwen Shao
Journal:  Front Pharmacol       Date:  2019-09-19       Impact factor: 5.810

3.  Activation of PPAR-β/δ Attenuates Brain Injury by Suppressing Inflammation and Apoptosis in a Collagenase-Induced Intracerebral Hemorrhage Mouse Model.

Authors:  Xiangming Tang; Kunning Yan; Yingge Wang; Yaping Wang; Hongmei Chen; Jiang Xu; Yaoyao Lu; Xiaohong Wang; Jingyan Liang; Xinjiang Zhang
Journal:  Neurochem Res       Date:  2020-01-14       Impact factor: 4.414

4.  Efficacy and safety of traditional Chinese medicine for intracranial hemorrhage by promoting blood circulation and removing blood stasis: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Wenjian Lin; Jingjing Hou; Tianxiong Han; Li Zheng; Huazheng Liang; Xiaoyu Zhou
Journal:  Front Pharmacol       Date:  2022-09-28       Impact factor: 5.988

Review 5.  Relevance of Porcine Stroke Models to Bridge the Gap from Pre-Clinical Findings to Clinical Implementation.

Authors:  Marc Melià-Sorolla; Carlos Castaño; Núria DeGregorio-Rocasolano; Luis Rodríguez-Esparragoza; Antoni Dávalos; Octavi Martí-Sistac; Teresa Gasull
Journal:  Int J Mol Sci       Date:  2020-09-08       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.